These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9139592)

  • 21. The significance of gemistocytes in astrocytoma.
    Yang HJ; Kim JE; Paek SH; Chi JG; Jung HW; Kim DG
    Acta Neurochir (Wien); 2003 Dec; 145(12):1097-103; discussion 1103. PubMed ID: 14663567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of p53 alterations in a case of gliomatosis cerebri.
    Mawrin C; Lins H; Kirches E; Schildhaus HU; Scherlach C; Kanakis D; Dietzmann K
    Hum Pathol; 2003 Jan; 34(1):102-6. PubMed ID: 12605375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
    Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
    Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression.
    Faria MH; Neves Filho EH; Alves MK; Burbano RM; de Moraes Filho MO; Rabenhorst SH
    APMIS; 2012 Nov; 120(11):882-9. PubMed ID: 23009112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathologic significance of proliferative activity and oncoprotein expression in astrocytic tumors.
    Bian XW; Shi JQ; Liu FX
    Anal Quant Cytol Histol; 2000 Dec; 22(6):429-37. PubMed ID: 11147296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M; Peraud A; Leroch B; Kreth FW
    Cancer; 2004 Sep; 101(5):1028-35. PubMed ID: 15329912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors.
    Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G
    Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [p53 and vascular endothelial growth factor expression in astrocytoma and their relation to angiogenesis].
    Ye S; Zhong X; Chen Y
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):326-9. PubMed ID: 11783119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P; Rathore A; Mathur M; Sarkar C; Mahapatra AK; Sinha S
    Oncogene; 1997 Aug; 15(7):871-4. PubMed ID: 9266974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced latency but no increased brain tumor penetrance in mice with astrocyte specific expression of a human p53 mutant.
    Klein MA; Rüedi D; Nozaki M; Dell EW; Diserens AC; Seelentag W; Janzer RC; Aguzzi A; Hegi ME
    Oncogene; 2000 Nov; 19(47):5329-37. PubMed ID: 11103934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brainstem gliomas--a clinicopathological study of 45 cases with p53 immunohistochemistry.
    Badhe PB; Chauhan PP; Mehta NK
    Indian J Cancer; 2004; 41(4):170-4. PubMed ID: 15659871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low level of microsatellite instability in paediatric malignant astrocytomas.
    Vladimirova V; Denkhaus D; Soerensen N; Wagner S; Wolff JE; Pietsch T
    Neuropathol Appl Neurobiol; 2008 Oct; 34(5):547-54. PubMed ID: 18053027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 protein expression in grade II astrocytomas: immunohistochemical study of 100 cases with long-term follow-up.
    Vital A; Loiseau H; Kantor G; Daucourt V; Chene G; Cohadon F; Rougier A; Rivel J; Vital C
    Pathol Res Pract; 1998; 194(12):831-6. PubMed ID: 9894248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-grade astrocytomas show increased Nestin and Wilms's tumor gene (WT1) protein expression.
    Rushing EJ; Sandberg GD; Horkayne-Szakaly I
    Int J Surg Pathol; 2010 Aug; 18(4):255-9. PubMed ID: 19578047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression.
    Bodey B; Gröger AM; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(2A):1187-94. PubMed ID: 9137469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas.
    Campos B; Bermejo JL; Han L; Felsberg J; Ahmadi R; Grabe N; Reifenberger G; Unterberg A; Herold-Mende C
    Cancer Sci; 2011 Feb; 102(2):387-92. PubMed ID: 21143702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors predicting progression of low-grade diffusely infiltrating astrocytoma.
    Ranjan M; Santosh V; Tandon A; Anandh B; Sampath S; Devi BI; Chandramouli BA
    Neurol India; 2011; 59(2):248-53. PubMed ID: 21483127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and mutation analysis of the p53 gene in astrocytoma.
    Hwang SL; Hong YR; Sy WD; Chai CY; Lin HJ; Howng SL
    J Formos Med Assoc; 1999 Jan; 98(1):31-8. PubMed ID: 10063271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.